Dataset Open Access

Data from: Safety of single low-dose primaquine in glucose-6-phosphate dehydrogenase deficient falciparum-infected African males: two open-label, randomized, safety trials

Bastiaens, Guido; Tiono, Alfred B.; Okebe, Joseph; Pett, Helmi; Coulibaly, Sam A.; Gonçalves, Bronner P.; Affara, Muna; Ouédraogo, Alphonse; Bougouma, Edith C.; Sanou, Guillaume S.; Nébié, Issa; Bradley, John; Lanke, Kjerstin H. W.; Niemi, Mikko; Sirima, Sodiomon B.; d'Alessandro, Umberto; Bousema, Teun; Drakeley, Chris; Bastiaens, Guido J. H.; Pett, Helmi E.; d'Alessandro, Umberto


DCAT Export

<?xml version='1.0' encoding='utf-8'?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:adms="http://www.w3.org/ns/adms#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dct="http://purl.org/dc/terms/" xmlns:dctype="http://purl.org/dc/dcmitype/" xmlns:dcat="http://www.w3.org/ns/dcat#" xmlns:duv="http://www.w3.org/ns/duv#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:frapo="http://purl.org/cerif/frapo/" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:gsp="http://www.opengis.net/ont/geosparql#" xmlns:locn="http://www.w3.org/ns/locn#" xmlns:org="http://www.w3.org/ns/org#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:prov="http://www.w3.org/ns/prov#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:schema="http://schema.org/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:vcard="http://www.w3.org/2006/vcard/ns#" xmlns:wdrs="http://www.w3.org/2007/05/powder-s#">
  <rdf:Description rdf:about="https://zenodo.org/record/4988492">
    <rdf:type rdf:resource="http://www.w3.org/ns/dcat#Dataset"/>
    <dct:type rdf:resource="http://purl.org/dc/dcmitype/Dataset"/>
    <dct:identifier rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://zenodo.org/record/4988492</dct:identifier>
    <foaf:page rdf:resource="https://zenodo.org/record/4988492"/>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Bastiaens, Guido</foaf:name>
        <foaf:givenName>Guido</foaf:givenName>
        <foaf:familyName>Bastiaens</foaf:familyName>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Tiono, Alfred B.</foaf:name>
        <foaf:givenName>Alfred B.</foaf:givenName>
        <foaf:familyName>Tiono</foaf:familyName>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Okebe, Joseph</foaf:name>
        <foaf:givenName>Joseph</foaf:givenName>
        <foaf:familyName>Okebe</foaf:familyName>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>Medical Research Council</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Pett, Helmi</foaf:name>
        <foaf:givenName>Helmi</foaf:givenName>
        <foaf:familyName>Pett</foaf:familyName>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Coulibaly, Sam A.</foaf:name>
        <foaf:givenName>Sam A.</foaf:givenName>
        <foaf:familyName>Coulibaly</foaf:familyName>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Gonçalves, Bronner P.</foaf:name>
        <foaf:givenName>Bronner P.</foaf:givenName>
        <foaf:familyName>Gonçalves</foaf:familyName>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Affara, Muna</foaf:name>
        <foaf:givenName>Muna</foaf:givenName>
        <foaf:familyName>Affara</foaf:familyName>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>Medical Research Council</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Ouédraogo, Alphonse</foaf:name>
        <foaf:givenName>Alphonse</foaf:givenName>
        <foaf:familyName>Ouédraogo</foaf:familyName>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Bougouma, Edith C.</foaf:name>
        <foaf:givenName>Edith C.</foaf:givenName>
        <foaf:familyName>Bougouma</foaf:familyName>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Sanou, Guillaume S.</foaf:name>
        <foaf:givenName>Guillaume S.</foaf:givenName>
        <foaf:familyName>Sanou</foaf:familyName>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Nébié, Issa</foaf:name>
        <foaf:givenName>Issa</foaf:givenName>
        <foaf:familyName>Nébié</foaf:familyName>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Bradley, John</foaf:name>
        <foaf:givenName>John</foaf:givenName>
        <foaf:familyName>Bradley</foaf:familyName>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>London School of Hygiene &amp; Tropical Medicine</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Lanke, Kjerstin H. W.</foaf:name>
        <foaf:givenName>Kjerstin H. W.</foaf:givenName>
        <foaf:familyName>Lanke</foaf:familyName>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>Radboud University Nijmegen</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Niemi, Mikko</foaf:name>
        <foaf:givenName>Mikko</foaf:givenName>
        <foaf:familyName>Niemi</foaf:familyName>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>University of Helsinki</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Sirima, Sodiomon B.</foaf:name>
        <foaf:givenName>Sodiomon B.</foaf:givenName>
        <foaf:familyName>Sirima</foaf:familyName>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>d'Alessandro, Umberto</foaf:name>
        <foaf:givenName>Umberto</foaf:givenName>
        <foaf:familyName>d'Alessandro</foaf:familyName>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Bousema, Teun</foaf:name>
        <foaf:givenName>Teun</foaf:givenName>
        <foaf:familyName>Bousema</foaf:familyName>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>Radboud University Nijmegen</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Drakeley, Chris</foaf:name>
        <foaf:givenName>Chris</foaf:givenName>
        <foaf:familyName>Drakeley</foaf:familyName>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Bastiaens, Guido J. H.</foaf:name>
        <foaf:givenName>Guido J. H.</foaf:givenName>
        <foaf:familyName>Bastiaens</foaf:familyName>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>Radboud University Nijmegen</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Pett, Helmi E.</foaf:name>
        <foaf:givenName>Helmi E.</foaf:givenName>
        <foaf:familyName>Pett</foaf:familyName>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>University of Helsinki</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>d'Alessandro, Umberto</foaf:name>
        <foaf:givenName>Umberto</foaf:givenName>
        <foaf:familyName>d'Alessandro</foaf:familyName>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>Medical Research Council</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:title>Data from: Safety of single low-dose primaquine in glucose-6-phosphate dehydrogenase deficient falciparum-infected African males: two open-label, randomized, safety trials</dct:title>
    <dct:publisher>
      <foaf:Agent>
        <foaf:name>Zenodo</foaf:name>
      </foaf:Agent>
    </dct:publisher>
    <dct:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#gYear">2018</dct:issued>
    <dcat:keyword>Plasmodium falciparum</dcat:keyword>
    <dcat:keyword>haemoglobin</dcat:keyword>
    <dcat:keyword>primaquine</dcat:keyword>
    <dcat:keyword>haemolysis</dcat:keyword>
    <dcat:keyword>safety</dcat:keyword>
    <dcat:keyword>gametocyte</dcat:keyword>
    <dcat:keyword>reticulocytes</dcat:keyword>
    <dcat:keyword>malaria</dcat:keyword>
    <dct:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2018-12-18</dct:issued>
    <owl:sameAs rdf:resource="https://zenodo.org/record/4988492"/>
    <adms:identifier>
      <adms:Identifier>
        <skos:notation rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://zenodo.org/record/4988492</skos:notation>
        <adms:schemeAgency>url</adms:schemeAgency>
      </adms:Identifier>
    </adms:identifier>
    <dct:relation rdf:resource="https://doi.org/10.1371/journal.pone.0190272"/>
    <owl:sameAs rdf:resource="https://doi.org/10.5061/dryad.230ps"/>
    <dct:isPartOf rdf:resource="https://zenodo.org/communities/dryad"/>
    <dct:description>Background: Primaquine (PQ) actively clears mature Plasmodium falciparum gametocytes but in glucose-6-phosphate dehydrogenase deficient (G6PDd) individuals can cause hemolysis. We assessed the safety of low-dose PQ in combination with artemether-lumefantrine (AL) or dihydroartemisinin-piperaquine (DP) in G6PDd African males with asymptomatic P. falciparum malaria. Methods and findings: In Burkina Faso, G6PDd adult males were randomized to treatment with AL alone (n = 10) or with PQ at 0.25 (n = 20) or 0.40 mg/kg (n = 20) dosage; G6PD-normal males received AL plus 0.25 (n = 10) or 0.40 mg/kg (n = 10) PQ. In The Gambia, G6PDd adult males and boys received DP alone (n = 10) or with 0.25 mg/kg PQ (n = 20); G6PD-normal males received DP plus 0.25 (n = 10) or 0.40 mg/kg (n = 10) PQ. The primary study endpoint was change in hemoglobin concentration during the 28-day follow-up. Cytochrome P-450 isoenzyme 2D6 (CYP2D6) metabolizer status, gametocyte carriage, haptoglobin, lactate dehydrogenase levels and reticulocyte counts were also determined. In Burkina Faso, the mean maximum absolute change in hemoglobin was -2.13 g/dL (95% confidence interval [CI], -2.78, -1.49) in G6PDd individuals randomized to 0.25 PQ mg/kg and -2.29 g/dL (95% CI, -2.79, -1.79) in those receiving 0.40 PQ mg/kg. In The Gambia, the mean maximum absolute change in hemoglobin concentration was -1.83 g/dL (95% CI, -2.19, -1.47) in G6PDd individuals receiving 0.25 PQ mg/kg. After adjustment for baseline concentrations, hemoglobin reductions in G6PDd individuals in Burkina Faso were more pronounced compared to those in G6PD-normal individuals receiving the same PQ doses (P = 0.062 and P = 0.022, respectively). Hemoglobin levels normalized during follow-up. Abnormal haptoglobin and lactate dehydrogenase levels provided additional evidence of mild transient hemolysis post-PQ. Conclusions: Single low-dose PQ in combination with AL and DP was associated with mild and transient reductions in hemoglobin. None of the study participants developed moderate or severe anemia; there were no severe adverse events. This indicates that single low-dose PQ is safe in G6PDd African males when used with artemisinin-based combination therapy.</dct:description>
    <dct:description>&lt;div class="o-metadata__file-usage-entry"&gt;SAFEPRIM Burkina Faso Adverse Events&lt;div class="o-metadata__file-description"&gt;Adverse events SAFEPRIM trial Burkina Faso&lt;/div&gt;&lt;div class="o-metadata__file-name"&gt;DRYAD_SAFEPRIM Burkina Faso Adverse Events.xlsx&lt;br&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="o-metadata__file-usage-entry"&gt;SAFEPRIM Gambia Adverse Events&lt;div class="o-metadata__file-description"&gt;Adverse events SAFEPRIM trial The Gambia&lt;/div&gt;&lt;div class="o-metadata__file-name"&gt;DRYAD_SAFEPRIM Gambia Adverse Events.xlsx&lt;br&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="o-metadata__file-usage-entry"&gt;DRYAD SAFEPRIM main dataset Burkina Faso&lt;div class="o-metadata__file-description"&gt;Laboratory results from clinical trial in Burkina Faso. Data include haemoglobin concentration, reticulocyte counts, full haematology and biochemistry.&lt;/div&gt;&lt;div class="o-metadata__file-name"&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="o-metadata__file-usage-entry"&gt;DRYAD SAFEPRIM main dataset The Gambia&lt;div class="o-metadata__file-description"&gt;Laboratory results from clinical trial in The Gambia. Data include haemoglobin concentration, reticulocyte counts, full haematology and biochemistry.&lt;/div&gt;&lt;div class="o-metadata__file-name"&gt;&lt;/div&gt;&lt;/div&gt;&lt;p&gt;Funding provided by: National Science Foundation&lt;br&gt;Crossref Funder Registry ID: http://dx.doi.org/10.13039/100000001&lt;br&gt;Award Number: BMGF OPP1034789&lt;/p&gt;</dct:description>
    <dct:spatial>
      <dct:Location>
        <locn:geographicName>The Gambia</locn:geographicName>
      </dct:Location>
    </dct:spatial>
    <dct:spatial>
      <dct:Location>
        <locn:geographicName>Burkina Faso</locn:geographicName>
      </dct:Location>
    </dct:spatial>
    <dct:accessRights rdf:resource="http://publications.europa.eu/resource/authority/access-right/PUBLIC"/>
    <dct:accessRights>
      <dct:RightsStatement rdf:about="info:eu-repo/semantics/openAccess">
        <rdfs:label>Open Access</rdfs:label>
      </dct:RightsStatement>
    </dct:accessRights>
    <dcat:distribution>
      <dcat:Distribution>
        <dct:license rdf:resource="https://creativecommons.org/publicdomain/zero/1.0/legalcode"/>
        <dcat:accessURL rdf:resource="https://zenodo.org/record/4988492"/>
      </dcat:Distribution>
    </dcat:distribution>
    <dcat:distribution>
      <dcat:Distribution>
        <dcat:accessURL rdf:resource="https://doi.org/10.5061/dryad.230ps"/>
        <dcat:byteSize>21686</dcat:byteSize>
        <dcat:downloadURL rdf:resource="https://zenodo.org/record/4988492/files/DRYAD_SAFEPRIM Burkina Faso Adverse Events.xlsx"/>
        <dcat:mediaType>application/vnd.openxmlformats-officedocument.spreadsheetml.sheet</dcat:mediaType>
      </dcat:Distribution>
    </dcat:distribution>
    <dcat:distribution>
      <dcat:Distribution>
        <dcat:accessURL rdf:resource="https://doi.org/10.5061/dryad.230ps"/>
        <dcat:byteSize>16923</dcat:byteSize>
        <dcat:downloadURL rdf:resource="https://zenodo.org/record/4988492/files/DRYAD_SAFEPRIM Gambia Adverse Events.xlsx"/>
        <dcat:mediaType>application/vnd.openxmlformats-officedocument.spreadsheetml.sheet</dcat:mediaType>
      </dcat:Distribution>
    </dcat:distribution>
    <dcat:distribution>
      <dcat:Distribution>
        <dcat:accessURL rdf:resource="https://doi.org/10.5061/dryad.230ps"/>
        <dcat:byteSize>131044</dcat:byteSize>
        <dcat:downloadURL rdf:resource="https://zenodo.org/record/4988492/files/DRYAD SAFEPRIM main dataset Burkina Faso.xlsx"/>
        <dcat:mediaType>application/vnd.openxmlformats-officedocument.spreadsheetml.sheet</dcat:mediaType>
      </dcat:Distribution>
    </dcat:distribution>
    <dcat:distribution>
      <dcat:Distribution>
        <dcat:accessURL rdf:resource="https://doi.org/10.5061/dryad.230ps"/>
        <dcat:byteSize>47726</dcat:byteSize>
        <dcat:downloadURL rdf:resource="https://zenodo.org/record/4988492/files/DRYAD SAFEPRIM main dataset The Gambia.xlsx"/>
        <dcat:mediaType>application/vnd.openxmlformats-officedocument.spreadsheetml.sheet</dcat:mediaType>
      </dcat:Distribution>
    </dcat:distribution>
  </rdf:Description>
</rdf:RDF>
16
0
views
downloads
Views 16
Downloads 0
Data volume 0 Bytes
Unique views 14
Unique downloads 0

Share

Cite as